Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1873 of 6351
-
Cheap drug could tame Leprosy's painful Flare-Ups
Disease control OngoingErythema Nodosum Leprosum (ENL) is a painful, debilitating complication of leprosy. Patients often require high doses of corticosteroids for prolonged periods. Thalidomide is expensive and not available in most countries. The use of corticosteroids for long periods is associated …
Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated Jun 26, 2026 15:37 UTC
-
Blood test and CT combo may spare rectal cancer patients a second surgery
Diagnosis CompletedThis single-center, parallel-group randomized controlled trial compared routine diverting loop ileostomy with a postoperative CRP/CT-guided selective ileostomy strategy in adults undergoing laparoscopic low anterior resection for stage II or III middle or lower rectal cancer afte…
Sponsor: Alexandria University • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
Could a chatbot help close the gap in genetic cancer testing?
Knowledge-focused Recruiting nowIn this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual care' that patients would receive. This comparison will enable the investigator…
Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New strategy aims to cut risks when emergency breathing tubes are needed
Disease control Recruiting nowThis study has to objective to assess, in adults' patients needing tracheal intubation because of vital distress, the effect of a combined strategy to reduce intubation-related morbidity. This strategy will associate systematic use of rocuronium as paralyzing agent to facilitate …
Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Brain radiation face-off: one big dose vs. several smaller ones
Disease control Recruiting nowBrain metastases (BM) are a common systemic cancer manifestation which incidence increases. Therapeutic options include whole-brain radiotherapy (WBRT), surgery, and stereotactic radiosurgery (SRS). The concept of "oligometastatic" cerebral disease (oligoBM) has emerged and led t…
Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New diabetes combo pill shows promise in Late-Stage trial
Disease control CompletedA multicenter, randomized, double blind, placebo controlled, parallel, phase Ⅲ study to evaluate the efficacy and safety of JW0201 added on in patients with type 2 diabetes mellitus who have inadequate glycemic control with C2202 and C2204
Phase 3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Jun 26, 2026 15:09 UTC
-
Which blood pressure drug better protects kidneys in severe pre-eclampsia?
Disease control CompletedSevere pre-eclamptic toxemia has a high incidence of renal complications. Rapid diagnosis and termination of pregnancy are still the gold standard main treatment for pre-eclampsia. Rapid control of blood pressure showed to provide protection against many adverse effects of preecl…
Phase 4 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug aimed at gut inflammation shows promise in early trial
Disease control OngoingThe protocol of this Phase 2 clinical trial consists of a double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy and safety of dupilumab in participants with moderately to severely active Ulcerative Colitis (UC) with an eosinophilic phenotype…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Experimental pill plus keytruda takes on tough cancers
Disease control OngoingThis study is a phase 1B/2 open-label, study to determine safety and preliminary efficacy of Q702 in combination with pembrolizumab in study subjects with advanced esophageal, gastric/GEJ, hepatocellular, and cervical cancers.
Phase 1/2 • Sponsor: Qurient Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New combo shrinks liver tumors in hard-to-treat colorectal cancer
Disease control CompletedThis study was a phase 2, single-arm, single-center clinical trial in which previously treated patients with unresectable colorectal cancer liver metastases.
Phase 2 • Sponsor: Meng Qiu • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could microneedling make scar treatment less painful and more effective?
Disease control CompletedThe goal of this clinical trial is to learn about the efficacy and safety of microneedling-assisted 5-fluorouracil delivery in comparison with intralesional 5-fluorouracil, intralesional corticosteroid, and microneedling with saline for the treatment of pathological scars.
Phase 4 • Sponsor: Alexandria University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New Antibody-Drug conjugate takes aim at Hard-to-Treat gynaecological cancers
Disease control OngoingIIMGN151-1001 is a Phase 1, first in human, open-label dose-escalation, optimization, and expansion study designed to characterize the safety, tolerability, pharmacokinetics (PK), immunogenicity, and preliminary antitumor activity of IMGN151 in adult participants with recurrent e…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can a phone call boost digital alcohol help?
Disease control OngoingThe purpose of the study is to evaluate the effects on alcohol consumption, and the consumption of time spent by a qualified clinician, by adding different forms of guidance to a digital intervention based on an alcohol diary and techniques from cognitive behavioral therapy and r…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a quick sweat and pupil test spot early signs of dementia?
Knowledge-focused Recruiting nowProspective interventional study with a device for comparing autonomic parameters among patients with different forms of cognitive decline
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Simple blood and tissue tests could revolutionize lung cancer care
Diagnosis Recruiting nowThis study is an observational study of blood and tissue biomarkers. Investigators plan to evaluate the accuracy of lung cancer biomarkers found in the blood in determining if a lung nodule is cancer or benign. Investigators also plan to examine another biomarker found in the tum…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New hope for tough breast cancer: experimental drug EP0062 enters human trials
Disease control Recruiting nowThe aim of this study is to identify the optimal dose for EP0062 as monotherapy and in combination with standard-of-care therapies to assess its Safety, Tolerability, Pharmacokinetics, and Efficacy in Patients with Relapsed Locally Advanced or Metastatic AR+/HER-2-/ER+ Breast Can…
Phase 1/2 • Sponsor: Ellipses Pharma • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New balloon treatment for clogged arteries shows promise
Disease control CompletedThis Clinical Evaluation Report (CER) covers the Mamba Sirolimus-Eluting PTCA Balloon catheter intended for the treatment of coronary artery disease in de novo or in-stent restenosis lesions. It includes analysis of clinical data from the MIRAGE clinical study, literature data on…
Phase 4 • Sponsor: Frisch Medical Device Private Limited • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Which pain block works better for breast surgery?
Symptom relief CompletedRegional/local analgesic techniques are an important component of a multimodal analgesic strategy, with the aim of reducing opioid requirements and opioid-related adverse events. This change parallels quality improvement initiatives and the Enhanced Recover after Surgery. Breast…
Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New triple-threat approach targets deadly mesothelioma in early trial
Disease control Recruiting nowThe study is a single-arm phase I trial to evaluate the safety, feasibility, and preliminary efficacy of the addition of pembrolizumab and image-guided resection to surgical therapy and chemotherapy for malignant pleural mesothelioma (MPM).
Phase 1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can a common drug stop dangerous bleeding in pregnancy?
Disease control CompletedAbruptio placenta is one of the common causes of antepartum haemorrhage which is more common in the second half of pregnancy and causes a high maternal and neonatal morbidity and mortality
Sponsor: Hawler Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC